What Does it Cover?
Immunohistochemistry has now been a staple in diagnostic pathology for decades. This is partially due to pathologist utilization of antibodies in the realm of specialty panels. As the science evolves, the panels evolve, creating demand for the next generation of antibodies to improve diagnostic capabilities. This talk will give an overview of some of these novel diagnostic markers and how they fit into the specialty panels with the traditional antibodies to provide the best diagnostic capabilities to the pathologist, therefore giving the patient the best care available.
What Will You Learn?
- The advancement in immunhistochemical methods
- New markers and how they fit within established diagnostic panels
- Demonstration of advanced staining on clinical samples
Who Should Attend?
- Histotechnologists
- Pathologists
- Oncologists
- Medical Directors
- Lab Managers
- Residents/Histotech Students
- Health Care Professionals
Speakers
Jeff Gordon
Merck
OEM Sales Manager
Jeff Gordon is the OEM Sales Manager for Tissue Diagnostics. He has a Bachelor of Science in Microbiology from the University of Arkansas. In his over 17 years in the diagnostic Immunohistochemistry industry, he has served as a technical consultant managing territories covering most of the United States and Canada, as International Sales Manager, and as the Director of Sales and Marketing for Cell Marque before transitioning to OEM Sales Manager for us. His roles have involved sales, marketing, customer care/complaint handling, and product development. He has given over 60 IHC-related workshops and webinars at a local, state, national, and international level.
Protein biology
- Clinical testing and diagnostics manufacturing
期間:57min
言語:English
セッション 1:presented December 5, 2018
続きを確認するには、ログインするか、新規登録が必要です。
アカウントをお持ちではありませんか？